COMPARISON OF THE THERAPEUTIC EFFICACY OF CONCOMITANT ADMINISTRATION OF LEVAMISOLE AND CLOBETASOL WITH CLOBETASOL IN VITILIGO

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NASERI MAHSA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S) Year:2006 | Volume:24 | Issue:82 Page(s): 40-43

Download Full-Text

Persian Verion

View:

14,059

Download:

Cites:

Information Journal Paper

Title

COMPARISON OF THE THERAPEUTIC EFFICACY OF CONCOMITANT ADMINISTRATION OF LEVAMISOLE AND CLOBETASOL WITH CLOBETASOL IN VITILIGO

Author(s)

NASERI MAHSA | Issue Writer Certificate

Keywords

LEVAMISOLEQ4

CLOBETASOLQ3

VITILIGOQ3

Abstract

Introduction: VITILIGO is an acquired pigmentary disorder of the skin and has significant harmful effects on the appearance and consequently Social functions of the patients. There is no universally effective treatment for this disease, but topical steroids and LEVAMISOLE have been used. This study evaluates the effects of LEVAMISOLE and CLOBETASOL with that of CLOBETASOL in the treatment of VITILIGO. Methods: Through a randomized clinical trial, 73 adult patients with VITILIGO were divided into two groups. The first group consisted of 37 patients and received LEVAMISOLE 150 mg daily for 2 consecutive days per week, and topical CLOBETASOL ointment 0.05% daily. The second group consisted of 36 patients and received topical CLOBETASOL ointment 0.05% daily. Treatment was continued for 4 months and 35 patients in each group completed the study. Of seventy patients who completed the study, 32 were males, and 3,8 were females aged between 18 and 55 years. In the first, group, 37.1% showed no response, another 37.1% had partial response and 25.8% showed complete response to treatment. In the second, group these 3 types of responses were observed in 25.7%, 54.3% and 20% of subjects, respectively. There was no statistically significant difference between the responses of the two groups.Conclusions: It seems that addition of LEVAMISOLE to d6betasol is not helpful in the treatment of VITILIGO.

Cites

No record.

References

No record.

Cite

APA: Copy

NASERI, MAHSA. (2006). COMPARISON OF THE THERAPEUTIC EFFICACY OF CONCOMITANT ADMINISTRATION OF LEVAMISOLE AND CLOBETASOL WITH CLOBETASOL IN VITILIGO. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), 24(82), 40-43. SID. https://sid.ir/paper/49650/en

Vancouver: Copy

NASERI MAHSA. COMPARISON OF THE THERAPEUTIC EFFICACY OF CONCOMITANT ADMINISTRATION OF LEVAMISOLE AND CLOBETASOL WITH CLOBETASOL IN VITILIGO. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)[Internet]. 2006;24(82):40-43. Available from: https://sid.ir/paper/49650/en

IEEE: Copy

MAHSA NASERI, “COMPARISON OF THE THERAPEUTIC EFFICACY OF CONCOMITANT ADMINISTRATION OF LEVAMISOLE AND CLOBETASOL WITH CLOBETASOL IN VITILIGO,” JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), vol. 24, no. 82, pp. 40–43, 2006, [Online]. Available: https://sid.ir/paper/49650/en

Related Journal Papers